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Purpose: To measure the maximum, objectively measured, accommodative amplitude, 
produced by pharmacologic stimulation.
Methods: Thirty-seven healthy subjects were enrolled, with a mean age of 20.2±1.1 years, cor-
rected visual acuity of 20/20, and mean spherical equivalent refraction (SER) =-0.83±1.60 diopters. 
For each subject, the right pupil was dilated with phenylephrine 10%. After 30 minutes, the pupil 
was measured, the left eye was patched, and the right eye was autorefracted. Pilocarpine 4% was 
then instilled in the right eye, followed by phenylephrine. At 45 minutes after the pilocarpine, 
autorefraction and pupil size were again measured.
Results: Mean pupil size pre- and postpilocarpine was 8.0±0.8 mm and 4.4±1.9 mm, respec-
tively. Pre- and postpilocarpine, the mean SER was -0.83±1.60 and -10.55±4.26 diopters, 
respectively. The mean pilocarpine-induced accommodative amplitude was 9.73±3.64 diopters. 
Five subjects had accommodative amplitudes $14.00 diopters. Accommodative amplitude was 
not significantly related to baseline SER (p-value =0.24), pre- or postpilocarpine pupil size 
(p-values =0.13 and 0.74), or change in pupil size (p-value =0.37). Iris color did not statistically 
significantly affect accommodative amplitude (p-value =0.83).
Conclusion: Following topically applied pilocarpine, the induced objectively measured 
accommodation in the young eye is greater than or equal to the reported subjectively measured 
voluntary maximum accommodative amplitude.
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Introduction
Using the subjective push-up technique, Duane1 demonstrated that accommodative 
amplitude declines with age and that the amplitudes for a given age had a wide vari-
ability. For example, for a 20 year old, Duane1 reported lower, mean, usual upper, and 
extreme upper limits for accommodative amplitude of 9.7, 11.5, 13.0, and 14.0 diopters, 
respectively. However, the reported, objectively measured, voluntary accommoda-
tive amplitude for this same age group, when assessed by dynamic retinoscopy2 
and autorefraction,3,4 had significantly lower means and less variability. Using these 
methods, the maximum mean accommodative amplitudes were 7.31±0.77 diopters2 
and 6.25±1.13 diopters,3 respectively. It was also reported that following one drop 
of pilocarpine 6% stimulated accommodation, the mean objectively measured mean 
accommodative amplitude for this age group was 5.05±3.05 diopters.5
Based upon these studies, it has been suggested that the maximum accommodative 
amplitude for the eye peaks and/or plateaus at approximately 8 diopters.4 To evaluate 
the upper limit of accommodative amplitude in young adults, we objectively measured 
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the change in refraction with an autorefractor following 
topical administration of pilocarpine.
Methods
subjects
To be included in this cohort study, the subjects had to 
be aged $18 years and #24 years. Each had to execute 
an informed consent and have a normal ophthalmological 
examination with best-corrected visual acuity of 20/20 
in the right eye with spherical equivalent refractive error 
between -5.00 diopters and +2.50 diopters. All methods 
adhered to the Tenets of the Declaration of Helsinki and 
the Health Insurance Portability and Accountability Act 
and were approved by the institutional review board at the 
Wielkopolska Medical Chamber, Poznan, Poland. Written 
informed consent was obtained from all participants.
Preliminary testing was performed to design the protocol 
for the frequency of administration of phenylephrine 10%, 
which has no effect on accommodative amplitude,6 and 
pilocarpine 4% required to maximize refractive change while 
minimizing miosis. Phenylephrine 10% was instilled in the 
right eye every minute for five applications. Thirty minutes 
later, using the right eye, the subject fixated on a nonaccom-
modative target within an autorefractor and the refraction 
and pupil size were measured. Pilocarpine 4%, 1 drop every 
minute three times, was placed in the right eye. Five minutes 
later, phenylephrine 10%, 1 drop every minute five times, 
was also placed in the right eye. Forty-five minutes later, 
autorefraction and pupil size measurements of the right eye 
were obtained. The left eye of the subject was patched, and 
the overall illumination of the examining room was kept 
constant during all measurements.
autorefraction, keratometry, and 
pupil size
The auto-keratorefractometer (KR8100A; Topcon Medical 
Systems, Oakland, NJ, USA) enabled keratometric measure-
ments (33.75–67.50 diopters) and closed-view refractive 
measurements (-25 to 22 diopters) through a pupil $2 mm. 
This model autorefractor has been used as a standard for 
comparing other refracting techniques and has an accuracy 
of approximately 0.25 diopters.7 The average of three refrac-
tions of the right eye of all subjects was measured with the 
autorefractor pre- and postpilocarpine instillation. The post-
pilocarpine change in refraction was defined as the change in 
accommodative amplitude.5 Using an IOLMaster 700 (Zeiss 
IOLMaster 700; Carl Zeiss Meditec AG, Jena, Germany), the 
pupils were measured three times pre- and postpilocarpine 
within approximately 1 minute after the autorefraction.
analysis
Descriptive statistics and linear regression were performed 
to assess the association of accommodative amplitude to 
prepilocarpine spherical equivalent refraction (SER), change 
in pupil size, and pre- and postpilocarpine pupil size. A box 
plot and a general linear model with univariate analysis of 
variance were performed to evaluate the effect of iris color 
(IC) on accommodative amplitude (IBM SSPS Statistics, 
Version 24; IBM Corporation, Armonk, NY, USA).
Results
Thirty-seven subjects were enrolled in the study, with a 
mean ± standard deviation age of 20.2±1.1 years and a mean 
prepilocarpine SER of -0.83±1.60 diopters. The color of the 
subjects’ irises (n) were blue (10), green (12), hazel (4), and 
brown (11). The mean pupil size pre- and postpilocarpine 
was 8.0±0.8 mm and 4.4±1.9 mm, respectively. The mean 
SER postpilocarpine was -10.55±4.26 diopters. The mean 
accommodative amplitude was 9.73±3.64 diopters.
Five of the subjects had accommodative ampli-
tudes $14.00 diopters. Two of these subjects had brown IC. 
The prepilocarpine mean keratometry (average of the steep 
and flat meridians) and refractive cylinder were 43.37±1.92 
diopters and 0.61±0.51 diopters, respectively. The post-
pilocarpine mean keratometry and refractive cylinder were 
43.15±1.58 diopters and 0.82±0.55 diopters, respectively 
(Table 1). Using linear regression, accommodative ampli-
tude was not statistically significantly related to baseline 
SER (r2=0.04, p-value =0.24), pre- or postpilocarpine pupil 
size (r2=0.07 and ,0.01, p-values =0.13 and 0.74, respec-
tively), or change in pupil size (r2=0.02, p-value =0.37). 
The mean accommodative amplitude for subjects with 
blue (10), green (12), hazel (4), and brown (11) irises was 
10.03 (95% CI: 7.54–12.19), 10.15 (95% CI: 8.08–12.01), 
10.14 (95% CI: 4.94–13.12), and 8.84 diopters (95% CI: 
6.64–11.12; Figure 1). From the general linear model, there 
was no statistically significant correlation between IC and 
amplitude of accommodation (r2=0.03, p-value =0.83).
In addition, green, hazel, and brown irises were pooled 
as dark when compared to blue irises (Figure 2). The mean 
accommodative amplitude for subjects with blue and dark 
irises was 10.03 (95% CI: 7.36–12.69) and 9.815 diopters 
(95% CI: 8.16–11.07), respectively. There was no statisti-
cal correlation between blue or dark IC and accommodative 
amplitude (r2,0.01, p-value =0.77).
Discussion
The objectively measured, pilocarpine stimulated, mean 
accommodative amplitude for the subjects of this study 
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Table 1 age, iC, pre- and postpilocarpine mean keratometry, ser, refractive cylinder, pupil size, and accommodative amplitude
Subject IC Age 
(years)
Prepilocarpine Postpilocarpine
Mean K 
(diopters)
SER 
(diopters)
Cyl 
(diopters)
Pupil 
(mm)
Mean K 
(diopters)
SER 
(diopters)
Cyl 
(diopters)
Pupil 
(mm)
AA 
(diopters)
1 Brown 24 43.87 -0.12 0.62 8.1 43.50 -10.25 0.87 3.4 10.13
2 Blue 20 45.62 0.00 1.12 6.6 45.50 -9.25 0.75 3.0 9.25
3 green 19 43.25 -0.37 0.25 7.2 43.50 -9.62 1.12 3.8 9.25
4 Brown 19 41.25 -0.62 0.12 9.1 41.12 -4.37 0.25 3.2 3.75
5 Blue 20 44.00 1.50 1.25 7.0 43.37 -9.75 0.50 7.2 11.25
6 Blue 20 42.37 -0.62 0.25 8.2 45.75 -16.00 0.75 7.4 15.38
7 hazel 20 39.50 1.37 0.37 8.2 40.37 -8.37 0.37 3.2 9.74
8 Blue 19 42.12 -0.75 0.75 7.6 42.25 -5.12 0.50 7.0 4.37
9 green 20 47.37 -4.25 1.00 7.7 44.00 -14.75 1.25 7.6 10.50
10 Blue 20 47.25 -0.62 0.25 6.6 43.87 -5.50 0.87 6.3 4.88
11 hazel 20 43.50 -0.75 0.87 8.2 43.25 -13.87 0.37 4.8 13.12
12 green 20 42.87 -0.37 0.37 8.6 42.25 -17.25 0.37 6.4 16.88
13 Brown 19 44.87 -1.25 0.50 8.7 44.87 -4.75 0.50 6.2 3.50
14 Blue 19 44.25 0.25 1.00 8.9 44.00 -13.37 1.75 6.9 13.62
15 hazel 19 40.62 0.75 0.50 8.4 40.62 -4.19 0.37 5.8 4.94
16 green 19 43.00 0.12 0.12 7.8 43.00 -4.31 0.12 7.6 4.43
17 green 19 44.62 -0.37 3.00 6.6 44.37 -3.87 2.87 3.7 3.50
18 Brown 22 42.37 -3.12 0.62 8.9 42.37 -19.37 1.37 6.5 16.25
19 Brown 22 42.75 -1.25 0.25 7.6 43.62 -9.75 1.37 6.2 8.50
20 Brown 19 42.87 1.62 0.75 5.6 42.75 -5.75 0.87 3.4 7.37
21 Blue 20 45.50 -1.37 0.62 8.6 45.00 -9.12 0.50 7.6 7.75
22 green 20 41.12 0.12 0.50 8.0 41.00 -10.62 0.50 4.5 10.74
23 green 20 43.12 -0.62 0.37 8.1 43.00 -13.12 1.12 3.0 12.50
24 green 21 45.25 -0.37 0.75 8.7 44.62 -10.62 1.62 2.4 10.25
25 Brown 21 44.00 -4.25 0.50 8.8 44.00 -14.50 0.75 2.7 10.25
26 Brown 19 44.75 -2.75 0.25 8.0 44.00 -17.00 1.25 2.7 14.25
27 green 19 41.75 0.00 0.00 8.7 41.50 -9.50 0.50 3.4 9.50
28 Blue 20 44.00 0.00 0.50 8.4 42.00 -14.00 1.50 2.6 14.00
29 Blue 21 45.25 0.25 0.50 8.3 45.00 -8.75 0.75 2.8 9.00
30 green 20 42.25 -4.25 1.00 7.8 42.75 -16.50 0.25 2.9 12.25
31 Brown 21 41.00 -1.50 0.50 7.0 41.00 -12.00 0.50 2.9 10.50
32 Brown 21 46.00 -0.25 0.75 7.8 46.00 -6.00 1.00 2.7 5.75
33 green 21 42.50 -1.00 0.50 7.4 42.25 -11.50 0.25 3.6 10.50
34 hazel 21 43.75 -1.00 0.50 8.0 43.25 -13.75 0.75 2.3 12.75
35 Brown 21 42.25 -1.25 0.75 8.9 42.75 -8.25 0.50 2.8 7.00
36 green 21 39.50 1.25 0.00 9.3 39.70 -10.25 0.75 3.1 11.50
37 Blue 21 45.00 -4.75 0.75 8.7 44.75 -15.50 0.75 2.3 10.75
Mean 20.2 43.37 -0.83 0.61 8.0 43.15 -10.55 0.82 4.4 9.73
sD 1.1 1.92 1.60 0.51 0.8 1.58 4.26 0.55 1.9 3.64
Median 20.0 43.25 -0.62 0.50 8.1 43.25 -10.25 0.75 3.4 10.25
Abbreviations: iC, iris color; K, keratometry; ser, spherical equivalent refraction; Cyl, refractive cylinder; aa, accommodative amplitude.
was 9.73 diopters. Eleven subjects had accommodative 
amplitudes $11.5 diopters, of whom five subjects had 
accommodative amplitudes $14.00 diopters. Although 
these measurements exceed the accommodative amplitudes 
reported in the modern literature,2–5 these measurements cor-
respond to the lower limit, mean, and extreme upper limit 
of Duane’s push-up measurements for 20-year-old subjects.1 
Following pilocarpine topical administration, the subjects 
in this study were capable of accommodating equal to or 
more than the reported subjective push-up measurement 
of voluntary accommodation for their age. A similar large 
accommodative response to pilocarpine was reported in 
healthy 25–29 year old subjects.8
To prevent poor autorefractive measurements, the effect 
of pupillary constriction from pilocarpine was mitigated by 
pretreatment with phenylephrine. As a result, pupil size was 
on average 4.4 mm, which was more than sufficient to obtain 
reliable autorefractions. When using this methodology, pupil 
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size was not statistically associated with accommodative 
amplitude. Consistent with the reported lack of change of 
corneal topography9,10 and lenticular astigmatism11 during 
accommodation, the mean change for both keratometry and 
refractive cylinder in this study was less than the repeatability 
of the autorefractor, ie, ,0.25 diopters. Although baseline 
subjective accommodative amplitude was not measured, it is 
unlikely that in the young healthy study subjects baseline 
push-up accommodative amplitude would have significantly 
differed from that reported by Duane,1,12 or that the magnitude 
of their subjective accommodation would have affected their 
autorefractor measured response to pilocarpine.5,13
One potential source of error is the variability of 
pilocarpine-induced ciliary muscle constriction in our 
subject population. There are a number of reasons that 
possibly explain this high degree of variation. Pilocarpine 
is bound and inactivated by melanin.14 Therefore, pigmented 
eyes containing higher amounts of melanin may experience 
less of a pharmacologic effect. In this study, IC did not have 
a statistically significant effect on accommodative amplitude; 
however, there was a large variation in accommodative 
amplitude in subjects with the same color iris (Figure 1). This 
large variation may be due to differing rates of pilocarpine 
absorption through the cornea and/or individual genetic 
differences in the metabolism of pilocarpine.15,16
An additional limitation of this study is that the subjects 
were in a narrow age group preventing a meaningful assess-
ment of the effect of age. However, previous clinical studies 
have shown that in older subjects pilocarpine can induce 
a greater accommodative response than anticipated from 
voluntary accommodation.8,17,18
Conclusion
To fully understand the mechanism of accommodation, 
it is important to accurately characterize the factors that 
limit accommodative amplitude. Since accommodation 
is effort based, recent studies may have underestimated 
the full accommodative amplitude in young subjects.2–5,13 
In accommodative studies, this demonstrates the importance 
of training and encouraging subjects to try to focus on the 
nearest target before assuming maximum voluntary accom-
modation.19 In addition, the results of this study assist in 
defining limits for mathematical parametric studies. And for 
patients with accommodative spasm, the results of this study 
can give an estimation for the severity of the spasm.
What was known
•	 In young subjects, objectively measured voluntary and 
pilocarpine-stimulated accommodative amplitude was 
less than push-up-measured voluntary accommodative 
amplitude.13
•	 In young subjects, objectively measured accommodative 
amplitude peaks or plateaus at 8 diopters.4
What this article adds
•	 When objectively measured, pilocarpine-stimulated 
accommodative amplitude was greater than previously 
reported voluntary-stimulated accommodative amplitude 
for healthy subjects aged 19–24 years.2–5,13
•	 In healthy subjects aged 19–24 years old, objectively mea-
sured pilocarpine-stimulated accommodative amplitude 
was equal to or greater than reported push-up-measured 
voluntary accommodative amplitude.1,12
Figure 1 Box plot of accommodative amplitude versus iris color showing the 
medians and 25% and 75% quartiles.
Abbreviations: aa, accommodative amplitude; iC, iris color.
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Figure 2 Box plot of accommodative amplitude versus blue and dark iris color 
showing the medians and 25% and 75% quartiles.
Abbreviations: aa, accommodative amplitude; iC, iris color.
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•	 In young subjects, the eye is capable of objectively 
accommodating significantly more than 8 diopters.
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